Carregant...
Structure-Based Design of Potent and Selective CK1γ Inhibitors
[Image: see text] Aberrant activation of the Wnt pathway is believed to drive the development and growth of some cancers. The central role of CK1γ in Wnt signal transduction makes it an attractive target for the treatment of Wnt-pathway dependent cancers. We describe a structure-based approach that...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American
Chemical Society
2012
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4025826/ https://ncbi.nlm.nih.gov/pubmed/24900428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml300278f |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|